In reference to emails from the NSE dated 25 April 2025, vide letter reference number NSE/CM/Surveillance/15393, and from BSE dated 25 April 2025, vide reference number L/SURV/ONL/PV/AJ/2025-2026/2960, seeking clarification regarding the recent movement in the price of the Company’s securities across exchanges, Hester Biosciences has informed that there is no pending information, announcement or event which, in opinion, may have a bearing on the price or volume behavior of the Company's securities. Further, there is no information that requires disclosure under Regulation 30 or any other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The movement in securities price and volume is purely due to market conditions and entirely market driven. The Company is neither connected to nor has any knowledge of any specific reason for the movement in price or volume.
The above information is a part of company’s filings submitted to BSE.
